We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · September 15, 2021

Long-Term Disability Progression and Employment in MS Patients on Dimethyl Fumarate

International Journal of MS Care

 

Additional Info

Disclosure statements are available on the authors' profiles:

International Journal of MS Care
Characterizing Long-Term Disability Progression and Employment in NARCOMS Registry Participants With Multiple Sclerosis Taking Dimethyl Fumarate
Int J MS Care 2021 Jul 09;[EPub Ahead of Print], A Salter, S Lancia, G Cutter, et al

Further Reading